Effective treatment for porphyria cutanea tarda with oral cimetidine.
Fujita
Yasuyuki
Y
Sato-Matsumura
Kazuko C
KC
D000624:5-Aminolevulinate Synthetase / Q000037:antagonists & inhibitors; D000368:Aged; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use*; D003306:Coproporphyrins / Q000652:urine; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006419:Heme Oxygenase (Decyclizing) / Q000037:antagonists & inhibitors; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D017119:Porphyria Cutanea Tarda / Q000188:drug therapy* / Q000473:pathology; D014575:Uroporphyrinogen Decarboxylase / Q000032:analysis / Q000172:deficiency
D000897:Anti-Ulcer Agents; D003306:Coproporphyrins; D004791:Enzyme Inhibitors; D006635:Histamine H2 Antagonists; D002927:Cimetidine; D006419:Heme Oxygenase (Decyclizing); D000624:5-Aminolevulinate Synthetase; D014575:Uroporphyrinogen Decarboxylase